EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach

Ding Tang iD, Siwen Wu, Youchun Wang, Weijin Huang iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ding Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIF…. Hauptthemen laut MEDLINE: HIV Infections, Epitopes, AIDS Vaccines, Viral Vaccines. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the current global health environment, the spread of the monkeypox virus (MPXV) and the persistent threat of human immunodeficiency virus (HIV) have become critical public health challenges. Since 2022, MPXV has rapidly disseminated worldwide, and nearly half of MPXV-infected individuals are co-infected with HIV. This complex situation calls for innovative preventive strategies. In this study, an innovative multi-epitope vaccine was designed using bioinformatics and immunoinformatic approaches. Ten HIV proteins and nine MPXV proteins were used to predict potential epitopes. Non-allergenic, highly antigenic, IFN-γ-inducible, and non-toxic epitopes were selected to construct the multi-epitope vaccine. It was found that the designed vaccine construct was highly antigenic, soluble, and had acceptable physicochemical properties. Based on molecular docking and molecular dynamics simulation (MDs) analyses, the vaccine construct demonstrated stable and robust interactions with Toll-like receptors (TLR2, TLR3, and TLR4). Although no actual animal experiments have been conducted to evaluate the vaccine’s effectiveness, immune simulations showed that the vaccine could elicit potent humoral and cell-mediated immune responses. Overall, this study provides a promising vaccine candidate against MPXV and HIV co-infection and emphasizes innovative strategies to interrupt the international transmission of these two viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsEpitopesAIDS VaccinesViral VaccinesHumansMolecular Docking SimulationMolecular Dynamics SimulationComputational BiologyHIV-1

Stichwörter der Autor:innen

HIVMPXVimmunoinformaticmulti-epitope vaccine

Substanzen

EpitopesAIDS VaccinesViral Vaccines

Autor:innen und Institutionen

  • Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China.
  • Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China.
  • Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming 650118, China.

ORCID-Profile: Ding Tang, Weijin Huang

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Tang, D., Wu, S., Wang, Y., & Huang, W. (2025). Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136313

Vancouver

Tang D, Wu S, Wang Y, Huang W. Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136313

BibTeX
@article{Tang2025,
  author = {Tang, Ding and Wu, Siwen and Wang, Youchun and Huang, Weijin},
  title = {Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136313}
}
Kostenlos starten →